Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, indicating a newer build of the study details page. This change does not modify study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new site version. The change appears to be a backend/software update without altering study content or user actions.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:04.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.0 to v3.6.2, signaling a new version of the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-06-26T20:53:29.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    New help and join-related sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now shows 'No longer looking for participants'. The 'Intervention/Treatment' label was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T11:37:26.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The revision label on the page has been updated to v3.5.5, replacing the previous v3.5.4. This indicates a new page version rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-05T08:50:26.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4 (replacing v3.5.3), indicating a new version of the page. This appears to be routine maintenance and does not alter study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:11.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.